Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

mannitol/infarction

リンクがクリップボードに保存されます
10 結果

Histidine-Tryptophan-Ketoglutarate Solution Versus Blood Cardioplegia in CABG

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
The Ethics Committee of Ain Shams university approved this randomized prospective double-blinded controlled parallel group study to be held in Cardiothoracic Academy for three months from December 2019 to April 2020. The study was conducted on three hundred and twenty older patients aged from 60-80

Adenosine Versus Verapamil for Management of Supraventricular Tachycardia Post- Coronary Artery Bypass Grafting

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Written informed consent was obtained from every patient. This prospective, double-blind, parallel-group clinical trial was conducted in 268 patients. The following inclusion criteria were used: (1) RCT; (2) adult (age: 65-70 years) patients with ASA physical status II and III, scheduled for

Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Lung cancer is the most common cancer, accounting for 20% of cancer-related deaths worldwide. In 2015, an estimated 610,200 patients (22 per cent of cancer-related deaths) died of lung cancer. Non-small cell lung cancer ((NSCLC)) accounts for 80% to 85% of lung cancer. Most patients are locally

Evaluation of the Safety and Efficacy of Hemacord HPC, Cord Blood in Subjects With Acute Ischemic Stroke

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
The primary objective of the study is to evaluate the safety of HPC, Cord Blood (administered via intravenous infusion and intrathecal injection, or intravenous infusion in conjunction with mannitol for subjects unable to tolerate intrathecal injection) in subjects with acute ischemic stroke. The

Molecular Mechanisms of Malignant Cerebral Edema After LHI

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
A total of 80 patients with acute large hemispheric infarction (LHI) within 48h after occurrence admitted into NICU of Xuanwu Hospital as well as 40 healthy volunteers will be recruited. The patients' baseline characteristics, treatment and changes of clinical conditions will be recorded, and ICP

Osmotic Agent Use in Middle Cerebral Artery Stroke

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
MCA Stroke is a fatal disease with reported mortality of about 80% of cases without decompressive craniectomy. Osmotic agents like hypertonic saline & mannitol have been used in acute MCA stroke cases without no evidence of benefit. Its use in elevated ICP can be only justified as a bridge to the

Stereotactic Infarct Tissue Aspiration for Malignant Infarction of Middle Cerebral Artery

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Malignant middle cerebral artery infarction (MMCI) has a fatality rate of up to 80%, due to massive brain edema, increased intracranial pressure, and cerebral herniation. The herniation-induced death usually occured during the first week, despite aggressive osmotherapy with mannitol or hypertonic

Remifentanil Anesthesia and Postoperative BIS in Cardiac Surgery

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Backgrounds Since opioid-based anesthesia does not produce dose-dependent myocardial depression, it has been applied for patients undergoing cardiac surgery with myocardial dysfunction. However, prolonged use of conventional opioids in a large dosage delays patient's postoperative recovery due to

Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5%

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Project title: Comparison of priming constituents in patients undergoing CPB assisted cardiac surgery: 6% HES 130/0.4 or Albumen 5% Principal investigator: Jo-Anne Marcoux M. Sc., CPC, CCP Department: Clinical Perfusion Sub-investigators: Victor Uppal B. Sc., CPC, CCP Taras Mycyk MD, FRCSC, Research

Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
Inclusion Criteria: - Stage III Chronic Kidney Disease (GFR 30-60ml/min per 1.73m2 calculated by using MDRD equation) - Inpatients at Norton Community Hospital scheduled to undergo diagnostic CT Scan using contrast between the hours of 7am and 6pm - 18+ years of age Exclusion Criteria - Current
Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge